3-苯基-3-氨基丙酸甲酯盐酸盐 | 88831-43-0

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 3-苯基-3-氨基丙酸甲酯盐酸盐
• 中文别名: 3-氨基-3-苯基丙酸甲酯盐酸盐
• 英文名称: methyl 3-amino-3-phenylpropionate hydrochloride
• 英文别名: methyl 3-amino-3-phenylpropanoate hydrochloride；β-phenyl-β-alanine methyl ester hydrochloride；3-amino-3-phenylpropionic acid methyl ester hydrochloride；methyl 3-amino-3-phenylpropanoate;hydrochloride
• CAS: 88831-43-0
• 化学式: C₁₀H₁₄NO₂*Cl
• mdl: MFCD00563398
• 分子量: 215.68
• InChiKey: GYKTZBZYSKZYDB-UHFFFAOYSA-N

物化性质

• 熔点：
  145-147℃

计算性质

• 辛醇/水分配系数(LogP)：
  1.02
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  52.3
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2922499990
• 危险性防范说明：
  P261,P280,P301+P312,P302+P352,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  室温，惰性气氛

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-Amino-3-phenyl-propionic acid methyl ester, HCl
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Amino-3-phenyl-propionic acid methyl ester, HCl
CAS number: 88831-43-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H13NO2.ClH
Molecular weight: 215.7

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-苯基-3-氨基丙酸甲酯盐酸盐 在 copper(II) bis(trifluoromethanesulfonate) 、 sodium carbonate 、 lithium hexamethyldisilazane 作用下， 以 四氢呋喃 、 二氯甲烷 、 水 、 叔丁醇 为溶剂， 反应 43.0h， 生成 (+/-)-methyl (4S,5R)-2-oxo-5-phenyl-1,3-oxazolidin-4-carboxylate
  参考文献：
  名称：

  Novel Synthesis of 4-Carboxymethyl 5-Alkyl/Aryl Oxazolidin-2-ones by Rearrangement of 2-Carboxymethyl 3-Alkyl/Aryl N-tert-Butoxycarbonyl Aziridines

  摘要：

  A two-step approach for the diastereoselective synthesis of 4-carboxymethyl 5-alkyl/aryl oxazolidin-2-ones is described, which proceeds via the intermediate formation of a carboxymethyl 3-alkyl/aryl N-tert-butoxycarbonyl (N-Boc) aziridines. By reaction of N-Boc p-amino methyl esters with LiHMDS and iodine, trans 2,3-disubstituted N-Boc aziridines are obtained with high stereoselectivities and yields. The final rearrangement to oxazolidin-2-ones is achieved by treatment with a catalytic amount of a Lewis acid and proceeds with high yield and complete regio and stereoselectivity.

  DOI：

  10.1021/ol991225l
• 作为产物：
  描述：

  DL-3-氨基-3-苯基丙酸 在 盐酸 作用下， 以 甲醇 为溶剂， 以98%的产率得到3-苯基-3-氨基丙酸甲酯盐酸盐
  参考文献：
  名称：

  Fast （III）与3,6,10-三（羧甲基）-3,6,10-三氮杂十二烷二酸（H 5 ttda）的新C-官能化衍生物的合成及理化性质表征，可快速交换水-潜在的顺磁报告者用于分子成像

  摘要：

  为了确认观察到[钆（TTDA）]衍生物具有显著较短的停留时间τ中号的协调ħ 2水分子比[钆（DTPA）]，四个新的C-官能[钆（TTDA）]配合物，[钆（4-Me-ttda）]（1），[Gd（4-Ph-ttda）]（2），[Gd（9-Me-ttda）]（3）和[Gd（9-Ph-ttda）制备并表征]（4）（H 5 ttda = 3,6,10-三（羧甲基）-3,6,10-三氮杂十二烷二酸; H 5 dtpa = 3,6,9-三（羧甲基）-3 ，6,9-三氮杂十二烷二酸）。这些配合物在0.47 T时质子弛豫率与H 2的17 O横向弛豫率的温度相关性在7.05 T处的17 O证实质子弛豫性不受H 2 O交换速率的限制。根据17 O-NMR数据计算，H 2 O分子在310配合物的第一个配位球中在310 K处的停留时间分别为13、43、2.9和56 ns（1、2、3和4）， 分别。在310 K时，纵

  DOI：

  10.1002/hlca.200790057

文献信息

• 羧基修饰的奥司他韦衍生物及其医药用途
  申请人：沈阳药科大学

  公开号：CN108101804B

  公开（公告）日：2020-08-04

  本发明属于药物化学领域，涉及羧基修饰的奥司他韦衍生物及其医药用途，具体涉及一类神经氨酸酶抑制剂奥司他韦的衍生物和其制备方法以及其医药用途，所述的衍生物及其药学上可接受的盐或异构体主要用于治疗由流感病毒引起的一系列感染疾病。具体的，本发明提供通式(Ⅰ)所示的化合物及其药学上可接受的盐、溶剂化物、多晶型体、对映体或外消旋混合物，其中R定义如权利要求和说明书所述。
• Transition Metal‐Free <i>N‐</i> Arylation of Amino Acid Esters with Diaryliodonium Salts
  作者：Gabriella Kervefors、Leonard Kersting、Berit Olofsson

  DOI：10.1002/chem.202005351

  日期：2021.3.26

  A transition metal‐free approach for the N‐arylation of amino acid derivatives has been developed. Key to this method is the use of unsymmetric diaryliodonium salts with anisyl ligands, which proved important to obtain high chemoselectivity and yields. The scope includes the transfer of both electron deficient, electron rich and sterically hindered aryl groups with a variety of different functional

  已经开发出一种用于氨基酸衍生物N芳基化的无过渡金属方法。该方法的关键是使用带有茴香基配体的不对称二芳基碘盐，这被证明对于获得高化学选择性和产率非常重要。范围包括缺电子、富电子和空间位阻芳基与各种不同官能团的转移。此外，环状二芳基碘鎓盐成功地用于芳基化。获得保留对映体过量的N-芳基化产物。
• [EN] INTEGRIN ANTAGONIST CONJUGATES FOR TARGETED DELIVERY TO CELLS EXPRESSING ALPHA-V-BETA-3<br/>[FR] CONJUGUÉS D'ANTAGONISTE DE L'INTÉGRINE POUR UNE ADMINISTRATION CIBLÉE À DES CELLULES EXPRIMANT L'ALPHA-V-BÊTA-3
  申请人：HOFFMANN LA ROCHE

  公开号：WO2013110578A1

  公开（公告）日：2013-08-01

  The invention relates to compounds of formula (I): wherein R1, R2, and n are defined in the detailed description and claims. In particular, the present invention relates to the compounds of formula (I) for use in the manufacture and delivery of conjugated moieties such as small molecules, peptides, nucleic acids, fluorescent moieties, and polymers which are linked to alpha-V-beta-3 integrin antagonists to target cells expressing alpha-V-beta-3.

  本发明涉及如下公式(I)的化合物：其中R1、R2和n在详细描述和权利要求中定义。特别是，本发明涉及用于制造和输送与alpha-V-beta-3整合素拮抗剂连接的共轭部分，如小分子、肽、核酸、荧光部分和聚合物，以针对表达alpha-V-beta-3的细胞的公式(I)的化合物。
• Isoxazoline and isoxazole fibrinogen receptor antagonists
  申请人：The DuPont Merck Pharmaceutical Company

  公开号：US05849736A1

  公开（公告）日：1998-12-15

  This invention relates to novel isoxazolines and isoxazoles which are useful as antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex or the vitronectin receptor, to pharmaceutical compositions containing such compounds, processes for preparing such compounds, and to methods of using these compounds, alone or in combination with other therapeutic agents, for the inhibition of platelet aggregation, as thrombolytics, and/or for the treatment of thromboembolic disorders.

  这项发明涉及新型异噁唑烷和异噁唑醇，其作为血小板糖蛋白IIb/IIIa纤维蛋白原受体复合物或维脱纳受体的拮抗剂，以及含有这些化合物的药物组合物，制备这些化合物的方法，以及使用这些化合物单独或与其他治疗剂联合用于抑制血小板聚集，作为溶栓剂，并/或用于治疗血栓栓塞性疾病。
• Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents
  作者：Tommaso Felicetti、Maria Sole Burali、Chin Piaw Gwee、Kitti Wing Ki Chan、Sylvie Alonso、Serena Massari、Stefano Sabatini、Oriana Tabarrini、Maria Letizia Barreca、Violetta Cecchetti、Subhash G. Vasudevan、Giuseppe Manfroni

  DOI：10.1016/j.ejmech.2020.112992

  日期：2021.1

  number of purification steps, the use of hazardous reagents and environmentally unsustainable generation of waste. Considering the promising antiviral activity of PBTZ analogues which require further exploration, in this work, we report the development of a new and sustainable three-component reaction (3CR) that can be combined with a basic hydrolysis in a one-pot procedure to obtain the PBTZ scaffold

  属于黄病毒属的蚊媒病毒，例如登革热病毒（DENV）和寨卡病毒（ZIKV），会引起人类感染，从轻度的流感样症状到出血热，肝炎和神经病。迄今为止，只有少数黄病毒的疫苗，而没有有效的治疗方法。 吡啶并苯并噻唑（PBTZ）衍生物是一类具有广阔前景的广谱抗黄病毒活性的化合物，据报道，其中大多数是黄病毒NS5聚合酶的有效抑制剂。然而，PBTZ类似物的合成需要大量的纯化步骤，危险试剂的使用以及对环境不可持续的废物的产生。 考虑到PBTZ类似物的有希望的抗病毒活性需要进一步探索，在这项工作中，我们报告了一种新的可持续的三组分反应（3CR）的开发，该反应可以与一锅法中的碱性水解反应结合使用PBTZ支架，从而减少了合成步骤，提高了产量并节省了时间。为了通过使用不同的起始材料来证明其广泛的应用范围，对3CR进行了广泛的研究。此外，利用这些程序，我们接下来设计和合成了一组新的PBTZ类似物，这些类似物已作为抗DE